1-(5-methyl-1-propyl-1H-pyrazol-4-yl)ethanone, 95.0%, 5g

(E)-4-((4-Hydroxyphenyl)diazenyl)benzoic acid, 96.0%, 250mg

Tenalisib, 10mg

Sofosbuvir impurity L, 5mg

2-Bromo-5-(methylsulfonyl)pyridine, 95.0%, 10g

6,7-Dihydro-5H-pyrrolo[3,4-d]pyrimidine dihydrochloride, 95.0%, 250mg

Syringe filters Minisart® NML Non-sterile, 1,2 µm, 500 Piece(s)

C-[5-(5-Trifluoromethyl-pyridin-2-yl)-[1,2,4]oxadiazol-3-yl]-methylamine; hydrochloride, 95.0%, 1g

2-Amino-6-chlorobenzoic acid, 95.0%, 5g

4-Hydroxythiophene-2-carbaldehyde, 1g

2-methyl-2-phenylpropanamide, 1g

1-Boc-3-(5-Bromopyrimidin-2-yloxy)piperidine, 95.0%, 1g

Methyl 1-hydroxy-1-cyclopropanecarboxylate, 95.0%, 1g